Literature DB >> 17112887

Elevated levels of serum interleukin-6 are associated with low grade cellular rejection in patients with heart transplantation.

F Perez-Villa1, B Benito, M Llancaqueo, A Cuppoletti, E Roig.   

Abstract

UNLABELLED: Endomyocardial biopsy is the gold-standard procedure to diagnose acute cellular rejection after heart transplantation. This study assessed whether the blood levels of cytokines involved in inflammation and immune activation are useful to detect the presence of acute cellular rejection.
METHODS: Blood specimens collected before 275 endomyocardial biopsies in 66 patients were assayed for levels of TNFalpha, IL6, IL1beta, and IL2 receptor. The biopsies were grouped according to the presence (n = 41) or absence (n = 234) of acute cellular rejection grade > or = 3A of the International Society for Heart and Lung Transplantation. We compared the levels of cytokines in the two groups.
RESULTS: Circulating IL6 levels were significantly higher when there was a low grade (0-2) cellular rejection in the biopsy versus the group of biopsies grade > or = 3A (19.8 +/- 27 versus 12.9 +/- 10 pg/mL; P = .001). An IL6 level higher than 30 pg/mL showed a negative predictive value of 95% for the presence of acute rejection grade > or = 3A.
CONCLUSION: In heart transplant patients, high levels of serum IL6 were associated with low grade cellular rejection. Determination of IL6 levels may be useful to reduce the number of endomyocardial biopsies during follow-up in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112887     DOI: 10.1016/j.transproceed.2006.08.113

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells.

Authors:  Birgit Fogal; Tai Yi; Chen Wang; Deepak A Rao; Amir Lebastchi; Sanjay Kulkarni; George Tellides; Jordan S Pober
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

2.  Comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions".

Authors:  Sibylle Neuhoff; Geoff T Tucker
Journal:  Pharm Res       Date:  2013-03-16       Impact factor: 4.200

3.  Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection.

Authors:  Nadine M Lerret; Ting Li; Jiao-Jing Wang; Hee-Kap Kang; Sheng Wang; Xueqiong Wang; Chunfa Jie; Yashpal S Kanwar; Michael M Abecassis; Xunrong Luo; Zheng Zhang
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

4.  Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study.

Authors:  R C Starling; J Stehlik; D A Baran; B Armstrong; J R Stone; D Ikle; Y Morrison; N D Bridges; P Putheti; T B Strom; M Bhasin; I Guleria; A Chandraker; M Sayegh; K P Daly; D M Briscoe; P S Heeger
Journal:  Am J Transplant       Date:  2015-08-10       Impact factor: 8.086

Review 5.  Rapid diagnosis of sepsis.

Authors:  Frank Bloos; Konrad Reinhart
Journal:  Virulence       Date:  2013-12-11       Impact factor: 5.882

6.  Single xenotransplant of rat brown adipose tissue prolonged the ovarian lifespan of aging mice by improving follicle survival.

Authors:  Liang-Jian Chen; Zhi-Xia Yang; Yang Wang; Lei Du; Yan-Ru Li; Na-Na Zhang; Wen-Yi Gao; Rui-Rui Peng; Feng-Yu Zhu; Li-Li Wang; Cong-Rong Li; Jian-Min Li; Fu-Qiang Wang; Qing-Yuan Sun; Dong Zhang
Journal:  Aging Cell       Date:  2019-08-06       Impact factor: 9.304

Review 7.  IL-6 Directed Therapy in Transplantation.

Authors:  Cynthia L Miller; Joren C Madsen
Journal:  Curr Transplant Rep       Date:  2021-06-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.